PL BioScience Names Ole Henrik Bang-Andreasen as New Board Member
AACHEN, Germany, Oct. 28, 2025 — PL BioScience GmbH, a German life science firm focused on developing and producing Human Platelet Lysate (HPL) for cell expansion and manufacturing, announced today the appointment of Ole Henrik Bang-Andreasen to its board of
More